Famotidine NDC 68071-3786

Product information

Brand name (proprietary)

Famotidine

Generic name (nonproprietary)

famotidine

Active ingredients

Famotidine — 20 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

NuCare Pharmaceuticals, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 215767

Marketing start

Nov 4, 2021

Listing expires

Dec 31, 2027

Other FDA classes

Histamine H2 Receptor Antagonists (Mechanism)

Identifiers

Product ID 68071-3786_5b9dabaa-dd52-0b29-e063-6294a90a9ff2SPL ID 5b9dabaa-dd52-0b29-e063-6294a90a9ff2

Pharmacologic class

Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071378603 followed by a unit qualifier and the quantity Copy

Package 68071-3786-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 215767

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.